Broker: UOB Kay Hian Date of Report: 6 June 2025 Duopharma Biotech: Riding the Insulin Wave – Robust Growth, Margin Upside, and Strategic Resilience for 2025 Overview: Duopharma Biotech’s Promising Outlook for Investors Duopharma Biotech Berhad, Malaysia’s leading pharmaceutical producer,...